Subsidy Tracker Parent Company Summary

Parent Company Name: 
Takeda Pharmaceutical
Ownership Structure: 
publicly traded
Headquartered in: 
Japan
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Subsidy SummarySubsidy ValueNumber of Awards
State/Local$43,056,16441
Federal (grants and allocated tax credits)$16,875,5295
TOTAL$59,931,69346
Loan / Bailout SummaryTotal Face ValueNumber of Awards
State/Local loans, bond financing and venture capital$00
Federal loans, loan guarantees and bailout assistance (not including repayments)$00
TOTAL$00
Time Period for State and Local Awards: 

Earliest year of data: 2000. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2009.

Time Period for Federal Awards: 

FY2000 to the present

Notes: 

Dollar totals do not include awards for which no subsidy value is disclosed.

Associated Names: 

ARIAD PHARMACEUTICALS; Baxalta. Inc.; BIOLIFE PLASMA SVC LP; DYAX; NPS PHARMACEUTICALS; SHIRE; TAKEDA PHARMACEUTICAL; TAKEDA PHARMACEUTICALS AMERICA; TAKEDA VACCINES; VIROPHARMA

Links: 

For a summary of this company's regulatory violations see its Violation Tracker summary page here.

For an overview of political contributions associated with this company, see its Follow the Money page.


Top 5 States for state/local awardsTotal Subsidy $Number of Awards
Massachusetts$18,357,4449
Illinois$10,688,3827
Pennsylvania$8,308,01315
New Jersey$4,371,2001
Maryland$807,5058
All other$523,6201

Individual Subsidy Records:

Download results as CSV or XML
Company Location Subsidy Source Year Subsidy Valuesort icon Loan/Bailout Value Type of Subsidy
SHIRE BIOLOGICS INC United States federal 2004 $9,500,092 federal grant
Shire HGT, Inc. Massachusetts state 2011 $5,855,368 tax credit/rebate
TAKEDA VACCINES, INC. United States federal 2018 $5,385,144 federal grant
Takeda Pharmaceuticals North America, Inc. Illinois state 2009 $4,511,785 tax credit/rebate
NPS Pharmaceuticals, Inc. New Jersey state 2003 $4,371,200 grant
Shire HGT, Inc. Massachusetts state 2011 $3,500,000 tax credit/rebate
Shire Human Genetic Therapies, Inc Massachusetts state 2012 $3,000,000 tax credit/rebate
Takeda Pharmaceuticals North America, Inc. Illinois state 2008 $2,034,824 tax credit/rebate
Shire Pharmaceuticals, Inc. Pennsylvania state $2,000,000 grant
Takeda Pharmaceuticals North America, Inc. Illinois state 2006 $1,384,120 tax credit/rebate
Baxalta. Inc. Massachusetts state 2016 $1,320,000 tax credit/rebate
ARIAD Pharmaceuticals, Inc. Massachusetts state 2013 $1,225,000 tax credit/rebate
Shire Holdings US, AG Pennsylvania state 2015 $1,223,167 tax credit/rebate
Shire Pharmaceuticals, Inc. Pennsylvania state $1,200,000 tax credit/rebate
Takeda Pharmaceuticals America, Inc. Massachusetts state 2016 $1,125,000 tax credit/rebate
Takeda Pharmaceuticals North America, Inc. Illinois state 2009 $1,105,019 tax credit/rebate
Shire Human Genetic Therapies Massachusetts state 2015 $985,000 tax credit/rebate
Takeda Pharmaceuticals North America, Inc. Illinois state 2005 $952,634 tax credit/rebate
Shire US Holdings, Inc. Pennsylvania state 2014 $914,646 tax credit/rebate
VIROPHARMA, INC United States federal 2003 $909,502 federal grant
Shire Human Genetic Therapies, Inc. Massachusetts state 2013 $750,000 tax credit/rebate
Shire Holdings US, AG Pennsylvania state 2016 $621,710 tax credit/rebate
Shire Human Genetic Therapies Massachusetts state 2014 $597,076 tax credit/rebate
Shire Holdings US, AG Maryland state 2004 $588,423 tax credit/rebate
DYAX CORPORATION United States federal 2000 $578,334 federal grant
BioLife Plasma Services L.P. Idaho state 2011 $523,620 training reimbursement
VIROPHARMA, INC United States federal 2003 $502,457 federal grant
Viropharma Incorporated Pennsylvania state $453,000 tax credit/rebate
Shire Pharmaceuticals Inc. Pennsylvania state 2008 $402,051 tax credit/rebate
Takeda Pharmaceuticals North America, Inc. Illinois state 2006 $350,000 grant
Takeda Pharmaceuticals North America, Inc. Illinois state 2007 $350,000 grant
Shire ViroPharma Incorporated Pennsylvania state 2015 $312,596 tax credit/rebate
Shire US Holdings, Inc. Pennsylvania state 2013 $255,775 tax credit/rebate
Shire Pharmaceuticals, Inc. Pennsylvania state 2009 $246,912 tax credit/rebate
Shire Pharmaceuticals, Inc. Pennsylvania state 2010 $228,422 tax credit/rebate
Shire Human Genetic Therapies, Inc. Pennsylvania state 2017 $160,094 tax credit/rebate
Shire Human Genetic Therapies, Inc. Pennsylvania state 2016 $118,253 tax credit/rebate
Shire ViroPharma, Inc. Pennsylvania state 2016 $85,794 tax credit/rebate
Shire Human Genetic Therapies, Inc. Pennsylvania state 2015 $85,593 tax credit/rebate
Shire Holdings US, AG Maryland state 2005 $53,032 tax credit/rebate
Shire Holding US AG Maryland state 2008 $33,609 tax credit/rebate
Shire US Manufacturing, Inc. Maryland state 2009 $30,126 tax credit/rebate
Shire Holdings US AG Maryland state 2007 $27,738 tax credit/rebate
Shire US Manufacturing, Inc. Maryland state 2004 $26,595 training reimbursement
Shire US Manufacturing, Inc. Maryland state 2008 $24,791 training reimbursement
Shire US Manufacturing Inc. Maryland state 2007 $23,191 training reimbursement
Takeda Pharmaceuticals North America, Inc. Illinois state 2005 undisclosed tax credit/rebate
Takeda Pharmaceuticals North America, Inc. Illinois state 2006 undisclosed tax credit/rebate
Takeda Pharmaceuticals North America, Inc. Illinois state 2007 undisclosed tax credit/rebate
Takeda Pharmaceuticals North America, Inc. Illinois state 2007 undisclosed tax credit/rebate
Takeda Pharmaceuticals North America, Inc. Illinois state 2008 undisclosed tax credit/rebate
Shire Human Genetics Therapies, Inc. Massachusetts state 2007 undisclosed tax credit/rebate
Takeda Pharmaceuticals America West Virginia state 2010 undisclosed tax credit/rebate
Download results as CSV or XML